Citation Impact
Citing Papers
Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor
2011
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
2015 StandoutNobel
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
2009
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
2012
A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma
2006
IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
2010
Systemic CTLA-4 Blockade Ameliorates Glioma-Induced Changes to the CD4+ T Cell Compartment without Affecting Regulatory T-Cell Function
2007 StandoutNobel
Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402
2006
Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH
2014
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Olig2-Regulated Lineage-Restricted Pathway Controls Replication Competence in Neural Stem Cells and Malignant Glioma
2007
Expression of Oligodendroglial and Astrocytic Lineage Markers in Diffuse Gliomas
2006
Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy
2011
Motoneurons and oligodendrocytes are sequentially generated from neural stem cells but do not appear to share common lineage-restricted progenitors in vivo
2006 StandoutNobel
Hox3 genes coordinate mechanisms of genetic suppression and activation in the generation of branchial and somatic motoneurons
2003 StandoutNobel
Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile
2008
Hallmarks of Cancer: The Next Generation
2011 Standout
The Oligodendroglial Lineage Marker OLIG2 Is Universally Expressed in Diffuse Gliomas
2004
Getting a GR(i)P on oligodendrocyte development
2003
Common Developmental Requirement for Olig Function Indicates a Motor Neuron/Oligodendrocyte Connection
2002
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
Nasopharyngeal carcinoma
2005 Standout
Acromegaly
2006 Standout
Sequential hormonal changes in 21 patients with recurrent Cushing's disease after successful pituitary surgery
2011
CD44: From adhesion molecules to signalling regulators
2003 Standout
MANAGEMENT OF ENDOCRINE DISEASE: The burden of Cushing's disease: clinical and health-related quality of life aspects
2012
Human immunodeficiency virus type 1–infected monocytic cells can destroy human neural cells after cell‐to‐cell adhesion
1992 StandoutNobel
IDH1andIDH2Mutations in Gliomas
2009 Standout
An ‘oligarchy’ rules neural development
2002
Early Identification of Refractory Epilepsy
2000 Standout
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Primary intracerebral malignant lymphoma: report of 248 cases
2000
Paraproteinemic Neuropathies
2001
Cushing's syndrome
2015 Standout
Glioblastoma and Other Malignant Gliomas
2013 Standout
Cabergoline monotherapy in the long-term treatment of Cushing's disease
2010
Molecular defects in the pathogenesis of pituitary tumours
2003
A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry
2010
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial
2005
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Correlation Among Pathology, Genotype, and Patient Outcomes in Glioblastoma
2006
Nelson's syndrome
2010
Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas
2010
Alzheimer's disease: amyloid plaques in the cerebellum
1989
Genomic characterization of the Neurofibromatosis Type 1 gene of Fugu rubripes
1998
A Randomized, Controlled Trial of Surgery for Temporal-Lobe Epilepsy
2001 Standout
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
2016 Standout
Neuropathological stageing of Alzheimer-related changes
1991 Standout
p53, MDM2, eIF4E and EGFR expression in nasopharyngeal carcinoma and their correlation with clinicopathological characteristics and prognosis: A retrospective study
2014
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
The 1p-Encoded Protein Stathmin and Resistance of Malignant Gliomas to Nitrosoureas
2007
Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease
2001 StandoutNobel
Loss of chromosome 22 alleles in human sporadic spinal schwannomas
1991
Exhaustive mutation analysis of theNF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects
2000
Improved Quality of Life After Bilateral Laparoscopic Adrenalectomy for Cushing's Disease
2007
Small cell astrocytoma: An aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma
2004
Mechanisms of Disease: genetic predictors of response to treatment in brain tumors
2007
Guidelines on management of low‐grade gliomas: report of an EFNS–EANO* Task Force
2010
von Hippel-Lindau disease
2003 Standout
Human microglial cells: Characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV‐1 infection
1991 StandoutNobel
Nasopharyngeal carcinoma
2015 Standout
Epidemiology of Brain Tumors
2007
Fugu: a compact vertebrate reference genome
2000 StandoutNobel
Anaplastic Oligodendroglioma and Oligoastrocytoma
2007
Quantitative imaging biomarkers in neuro-oncology
2009
Estrogen Receptors in Human Nontarget Tissues: Biological and Clinical Implications*
1995
Malignant Gliomas in Adults
2008 Standout
The 2004 World Health Organization classification of pituitary tumors: What is new?
2005
Meningioma Grading
1997
Parental origin of chromosome 22 loss in sporadic and NF2 neuromas
1991
The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey
2008 StandoutNobel
A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor
1993 Standout
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center
2012
Outcome of Bilateral Adrenalectomy in Cushing's Syndrome: A Systematic Review
2013
DIAGNOSTIC VALUE OF PROTON MAGNETIC RESONANCE SPECTROSCOPY IN THE NONINVASIVE GRADING OF SOLID GLIOMAS
2009
Oligodendroglioma: Toward Molecular Definitions in Diagnostic Neuro-Oncology
2003
Primary brain tumours in adults
2003
Stem Cells and Cancer
2004 Standout
Primary brain tumours in adults
2012 Standout
Molecular basis of agonism and antagonism in the oestrogen receptor
1997 StandoutNature
Survey of treatment recommendations for anaplastic oligodendroglioma
2007
Mechanisms for pituitary tumorigenesis: the plastic pituitary
2003
The biopsychosocial approach to chronic pain: Scientific advances and future directions.
2007 Standout
Development and Heterogeneity of Prolactin Cells
1995
Endolymphatic Sac Tumor: Unique Features of two Cases and Review of the Literature
2002
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Cushing's syndrome
2006 Standout
Pituitary Lactotroph Hyperplasia and Chronic Hyperprolactinemia in Dopamine D2 Receptor-Deficient Mice
1997
Identification of human brain tumour initiating cells
2004 StandoutNature
Mitotane, Metyrapone, and Ketoconazole Combination Therapy as an Alternative to Rescue Adrenalectomy for Severe ACTH-Dependent Cushing's Syndrome
2011
Epidermal growth factor receptor and Ink4a/Arf
2002
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma
2014
Molecular characterization of chromosome 22 deletions in schwannomas
1992
Molecular Diagnosis of Epstein-Barr Virus-Related Diseases
2001
Minor Lesion Mutational Spectrum of the Entire NF1 Gene Does Not Explain Its High Mutability but Points to a Functional Domain Upstream of the GAP-Related Domain
2000
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
2011
Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial
2010
mTOR Promotes Survival and Astrocytic Characteristics Induced by Pten/Akt Signaling in Glioblastoma
2005
Brain Tumors
2001 Standout
Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease
2000
Primary lymphoma of the central nervous system: just DLBCL or not?
2008
Primary CNS Lymphoma in Immunocompetent Patients
2009
The 2007 WHO Classification of Tumours of the Central Nervous System
2007 Standout
Approach to the Cushing's Disease Patient With Persistent/Recurrent Hypercortisolism After Pituitary Surgery
2013
Pten signaling in gliomas
2002
Use of an Orthotopic Xenograft Model for Assessing the Effect of Epidermal Growth Factor Receptor Amplification on Glioblastoma Radiation Response
2006
Immunochemical and immunocytochemical localization of S-100 antigen in normal human skin
1981 Nature
The Thy-1-bearing cell of murine epidermis. A distinctive leukocyte perhaps related to natural killer cells.
1985 StandoutNobel
NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology
2011
Development of a histological pseudocapsule and its use as a surgical capsule in the excision of pituitary tumors
2006
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
The Diagnostic Evaluation and Multidisciplinary Management of Neurofibromatosis 1 and Neurofibromatosis 2
1997 Standout
Tumorigenic cell culture lines from a spontaneous VM/Dk murine astrocytoma (SMA)
1980
End Point Assessment in Gliomas: Novel Treatments Limit Usefulness of Classical Macdonald's Criteria
2009
Association of Lhermitte-Duclos and Cowden disease: report of a new case and review of the literature.
1994
Pten signaling in gliomas
2002
SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma
2015
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Genetic determinants of malignancy in a mouse model for oligodendroglioma.
2003
Is the underlying cause of epilepsy a major prognostic factor for recurrence?
1998 Standout
The 2007 WHO Classification of Tumours of the Central Nervous System
2010 Standout
Ineffectiveness of Rosiglitazone Therapy in Nelson’s Syndrome
2007
Human immunodeficiency virus can productively infect cultured human glial cells.
1987
The Definition of Primary and Secondary Glioblastoma
2012
Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.
2003
Angiogenesis in Endocrine Tumors
2003
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
2010 Standout
Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors.
1994
Pituitary Magnetic Resonance Imaging Findings Do Not Influence Surgical Outcome in Adrenocorticotropin-Secreting Microadenomas
2004
Works of M. Kujas being referenced
Corticotroph Tumor Progression after Adrenalectomy in Cushing’s Disease: A Reappraisal of Nelson’s Syndrome
2006
Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice
2003
Primary Central Nervous System Lymphomas in 72 Immunocompetent Patients: Pathologic Findings and Clinical Correlations
1998
Normal Pituitary Hypertrophy as a Frequent Cause of Pituitary Incidentaloma: A Follow-Up Study
2001
Prognostic significance of imaging contrast enhancement for WHO grade II gliomas
2008
Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5' part of the gene
1995
Pituitary carcinoma: Report of an exceptional case and review of the literature
2002
BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas
2007
Dynamic history of low‐grade gliomas before and after temozolomide treatment
2007
The Nelson's syndrome... revisited
2004
Idiopathic granulomatous hypophysitis: clinical and imaging features
1997
A uniform activated B-cell–like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases
2005
Evaluation of 29 Monoclonal and Polyclonal Antibodies Used in the Diagnosis of Pituitary Adenomas
1991
Assessment of chromosome 22 anomalies in neurinomas by combined karyotype and RFLP analyses
1990
Prognostic stratification of patients with anaplastic gliomas according to genetic profile
2006
Lhermitte-Duclos disease (dysplastic gangliocytoma of the cerebellum)
1990
Immunocytochemical study of progesterone receptor in human meningioma
1992
MGMT methylation: A marker of response to temozolomide in low‐grade gliomas
2006
Papillary adenoma of endolymphatic sac origin: a temporal bone tumor in von Hippel—Lindau disease
1997
Growth hormone and somatostatin gene expression in pituitary adenomas with active acromegaly and minimal plasma growth hormone elevation
1990
Two types of chromosome 1p losses with opposite significance in gliomas
2005
Tumor genomic profiling and TP53 germline mutation analysis of first-degree relative familial gliomas
2007
Pituitary Enlargement with Suprasellar Extension in Functional Hyperprolactinemia due to Lactotroph Hyperplasia: A Pseudotumoral Disease
1991
Interactions between normal and tumoral tissues at the boundary of human anterior pituitary adenomas
1994
Glioblastomas with an Oligodendroglial Component: A Pathological and Molecular Study
2001
Immunocytochemistry of four mixed pituitary adenomas and intrasellar gangliocytomas associated with different clinical syndromes: Acromegaly, amenorrhea-galactorrhea, Cushing's disease and isolated tumoral syndrome
1989
Pathological findings in three non-japanese patients with the POEMS syndrome
1988
Specific alterations of the basement membrane and stroma antigens in Human pituitary tumours in comparison with the normal anterior pituitary. An immunocytochemical study
1992
In vivo transcranial brain surgery with an ultrasonic time reversal mirror
2007
OLIG2 as a specific marker of oligodendroglial tumour cells
2001
GFA and S 100 Protein Levels as an Index for Malignancy in Human Gliomas and Neurinomas2
1979
P18 tumor suppressor gene and progression of oligodendrogliomas to anaplasia
2000
Chromosome 1p loss: A favorable prognostic factor in low‐grade gliomas
2005
Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas
2006
Variations of mitotic activity in the adenohypophysis of male Rats during a 24-Hour cycle
1975
Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression
2001
Correlations between molecular profile and radiologic pattern in oligodendroglial tumors
2004
[Primary non-Hodgkin's malignant lymphoma of the central nervous system].
1992
Temozolomide As Initial Treatment for Adults With Low-Grade Oligodendrogliomas or Oligoastrocytomas and Correlation With Chromosome 1p Deletions
2004